Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 34 articles: HTML format

Single Articles

February 2023
1. RAMI-PORTA R, Fong KM
   Stage IV lung cancer: the relevance of tumour profile for the construction of prognostic groups.
   Eur Respir J. 2023;61:2202094.
   PubMed    
   
   
   
2. GOZAL D, Kolb M
   Nintedanib in chILD: a small step, yes... but at least a step forward in a marathon!
   Eur Respir J. 2023;61:2201797.
   PubMed    
   
   
   January 2023
3. WANG XF, Li QY
   Optimised surveillance of minor to moderate bronchial dysplasia in a risky population: more precision strategies needed.
   Eur Respir J. 2023;61:2202264.
   PubMed    
   
   
   December 2022
4. EYMIN B
   Inspiratory hyperoxia: a new way to prevent metastasis through metabolism reprogramming in non-small cell lung cancer.
   Eur Respir J. 2022;60:2201357.
   PubMed    
   
   
   
5. CRESTANI B, Kolb M
   Lung cancer in pulmonary fibrosis: no room for nihilism!
   Eur Respir J. 2022;60:2201946.
   PubMed    
   
   
   
6. ZHANG L, Lu FY, Huang SG, Li QY, et al
   Ventilation and tumour spread: still a pending matter.
   Eur Respir J. 2022;60:2201674.
   PubMed    
   
   
   
7. LOPEZ-ALONSO I, Fueyo A, Albaiceta GM
   Reply to: Ventilation and tumour spread: still a pending matter.
   Eur Respir J. 2022;60:2201826.
   PubMed    
   
   
   November 2022
8. BLUM TG, Morgan RL, Durieux V, Chorostowska-Wynimko J, et al
   European Respiratory Society Guideline on various aspects of quality in lung cancer care.
   Eur Respir J. 2022 Nov 17. pii: 13993003.03201-2021.
   PubMed     Abstract available
   
   
   
9. MAGENHEIM J, Rokach A, Peretz A, Loyfer N, et al
   Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
   Eur Respir J. 2022;60.
   PubMed     Abstract available
   
   
   September 2022
10. METZENMACHER M, Griesinger F, Hummel HD, Elender C, et al
    Prognostic factors in non-small-cell lung cancer: insights from the German crisp registry.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01336-2022.
    PubMed     Abstract available
    
    
    
11. GUISIER F, Deslee G, Birembaut P, Escarguel B, et al
    Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
    Eur Respir J. 2022;60.
    PubMed     Abstract available
    
    
    August 2022
12. STANOJEVIC S, Kaminsky DA, Miller M, Thompson B, et al
    Reply: The new ERS/ATS standards on lung function test interpretation: some extant limitations.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
13. NEDER JA
    The new ERS/ATS standards on lung function test interpretation: some extant limitations.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    July 2022
14. TISI S, Dickson JL, Horst C, Quaife SL, et al
    Detection of COPD in the SUMMIT Study Lung Cancer Screening Cohort using Symptoms and Spirometry.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00795-2022.
    PubMed     Abstract available
    
    
    
15. CROSBIE PAJ, Gabe R, Simmonds I, Hancock N, et al
    Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00483-2022.
    PubMed     Abstract available
    
    
    
16. KALINKE L, Janes SM
    Two phenotypes that predict prognosis in lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed    
    
    
    
17. LAMORT AS, Kaiser JC, Pepe MAA, Lilis I, et al
    Prognostic phenotypes of early-stage lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed     Abstract available
    
    
    
18. LOPEZ-ALONSO I, Lopez-Martinez C, Martin-Vicente P, Amado-Rodriguez L, et al
    Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content.
    Eur Respir J. 2022;60.
    PubMed     Abstract available
    
    
    June 2022
19. LIU X, Qin H, Li Z, Lv Y, et al
    Inspiratory hyperoxia suppresses lung cancer metastasis through a MYC/SLC1A5-dependent metabolic pathway.
    Eur Respir J. 2022 Jun 9. pii: 13993003.00062-2022.
    PubMed     Abstract available
    
    
    May 2022
20. OKI M, Saka H, Imabayashi T, Himeji D, et al
    Guide sheath versus non-guide sheath method for endobronchial ultrasound-guided biopsy of peripheral pulmonary lesions: a multicentre randomised trial.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    March 2022
21. OTSUBO K, Kishimoto J, Ando M, Kenmotsu H, et al
    Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial.
    Eur Respir J. 2022 Mar 31. pii: 13993003.00380-2022.
    PubMed     Abstract available
    
    
    
22. SUCCONY L, Gomez-Lopez S, Pennycuick A, Alhendi ASN, et al
    Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available
    
    
    January 2022
23. SUN TY, Hwang G, Pancirer D, Hornbacker K, et al
    Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
    Eur Respir J. 2022;59.
    PubMed    
    
    
    December 2021
24. ZHANG J, Guo JR, Huang ZS, Fu WL, et al
    Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial.
    Eur Respir J. 2021;58.
    PubMed     Abstract available
    
    
    November 2021
25. SOROLLA A, Parisi E, Sorolla MA, Marques M, et al
    Applications of CRISPR technology to lung cancer research.
    Eur Respir J. 2021 Nov 4. pii: 13993003.02610-2021.
    PubMed    
    
    
    October 2021
26. SCHREUDER A, Jacobs C, Lessmann N, Broeders MJ, et al
    Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility.
    Eur Respir J. 2021 Oct 14. pii: 13993003.01613-2021.
    PubMed     Abstract available
    
    
    
27. HENDRIKS LEL, van Meerbeeck J, Cadranel J
    Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?
    Eur Respir J. 2021;58.
    PubMed    
    
    
    
28. ASFAHAN S, Elhence P, Dutt N, Niwas Jalandra R, et al
    Digital-Rapid On-site Examination in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (DEBUT): a proof of concept study for the application of artificial intelligence in the bronchoscopy suite.
    Eur Respir J. 2021;58.
    PubMed    
    
    
    September 2021
29. HENROT P, Beaufils F, Thumerel M, Eyraud E, et al
    Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
    Eur Respir J. 2021 Sep 24. pii: 13993003.01221-2021.
    PubMed    
    
    
    July 2021
30. LI G, Zhang X, Liu Y, Zhang J, et al
    Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
    Eur Respir J. 2021 Jul 29. pii: 13993003.01399-2021.
    PubMed     Abstract available
    
    
    June 2021
31. CHERNBUMROONG S, Johnson J, Gupta N, Miller S, et al
    Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    April 2021
32. MALDONADO F, Varghese C, Rajagopalan S, Duan F, et al
    Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    
    March 2021
33. HASANI AM, Matthew B, Goljamali M, Chen YC, et al
    Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.
    Eur Respir J. 2021;57.
    PubMed    
    
    
    
34. FERNANDES S, Williams G, Williams E, Ehrlich K, et al
    Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
    Eur Respir J. 2021;57.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: